feed,title,long_url,short_url
Benzinga,Kezar Life Sciences Discontinues Unpromising Phase 1 Solid Tumor Drug,https://benzinga.com/general/biotech/24/08/40372756/kezar-life-sciences-discontinues-unpromising-phase-1-solid-tumor-drug,https://da.gd/7CbZc
